Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Increased peripheral CD4 + regulatory T cells persist after successful direct-acting antiviral treatment of chronic hepatitis C
Bettina Langhans, Hans Dieter Nischalke, Benjamin Krämer, et al.
Journal of Hepatology (2016) Vol. 66, Iss. 5, pp. 888-896
Closed Access | Times Cited: 88

Showing 1-25 of 88 citing articles:

The oncologic burden of hepatitis C virus infection: A clinical perspective
Harrys A. Torres, Terri Lynn Shigle, Nassim Hammoudi, et al.
CA A Cancer Journal for Clinicians (2017) Vol. 67, Iss. 5, pp. 411-431
Open Access | Times Cited: 98
<p>Hepatocellular Carcinoma Mechanisms Associated with Chronic HCV Infection and the Impact of Direct-Acting Antiviral Treatment</p>
Srikanta Dash, Yücel Aydın, Kyle E Widmer, et al.
Journal of Hepatocellular Carcinoma (2020) Vol. Volume 7, pp. 45-76
Open Access | Times Cited: 91
Viral hepatitis update: Progress and perspectives
María Belén Pisano, Cecilia Graciela Giadans, Diego Flichman, et al.
World Journal of Gastroenterology (2021) Vol. 27, Iss. 26, pp. 4018-4044
Open Access | Times Cited: 66
A Tale of Two Viruses: Immunological Insights Into HCV/HIV Coinfection
Samaa T. Gobran, Petronela Ancuța, Naglaa H. Shoukry
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 62
Regulatory T cells (Tregs) in liver fibrosis
Kejia Wu, Qufei Qian, Jinren Zhou, et al.
Cell Death Discovery (2023) Vol. 9, Iss. 1
Open Access | Times Cited: 38
Hepatitis C virus and hepatocellular carcinoma: carcinogenesis in the era of direct-acting antivirals
Felix Fiehn, Claudia Beisel, Marco Binder
Current Opinion in Virology (2024) Vol. 67, pp. 101423-101423
Open Access | Times Cited: 9
Chronic hepatitis C virus infection irreversibly impacts human natural killer cell repertoire diversity
Benedikt Strunz, Julia Hengst, Katja Deterding, et al.
Nature Communications (2018) Vol. 9, Iss. 1
Open Access | Times Cited: 76
Advances in the treatment of HIV/HCV coinfection in adults
Stefan Schlabe, Jürgen K. Rockstroh
Expert Opinion on Pharmacotherapy (2017) Vol. 19, Iss. 1, pp. 49-64
Closed Access | Times Cited: 64
T cell immunity to hepatitis C virus: Lessons for a prophylactic vaccine
Robert Thimme
Journal of Hepatology (2020) Vol. 74, Iss. 1, pp. 220-229
Open Access | Times Cited: 61
Metabolic dysfunction and cancer in HCV: Shared pathways and mutual interactions
Jack Leslie, Daniel Geh, Ahmed M. Elsharkawy, et al.
Journal of Hepatology (2022) Vol. 77, Iss. 1, pp. 219-236
Open Access | Times Cited: 37
Unmet needs in the post-direct-acting antivirals era: The risk and molecular mechanisms of hepatocellular carcinoma after hepatitis C virus eradication
Chung‐Feng Huang, Manar Hijaze Awad, Meital Gal-Tanamy, et al.
Clinical and Molecular Hepatology (2024) Vol. 30, Iss. 3, pp. 326-344
Open Access | Times Cited: 6
On-treatment decrease of NKG2D correlates to early emergence of clinically evident hepatocellular carcinoma after interferon-free therapy for chronic hepatitis C
Po‐Sung Chu, Nobuhiro Nakamoto, Nobuhito Taniki, et al.
PLoS ONE (2017) Vol. 12, Iss. 6, pp. e0179096-e0179096
Open Access | Times Cited: 61
Epigenetic scars in regulatory T cells are retained after successful treatment of chronic hepatitis C with direct-acting antivirals
So Young Kim, June‐Young Koh, Dong Hyeon Lee, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 5
Molecular Mechanisms Involved in HCC Recurrence after Direct-Acting Antiviral Therapy
Rosanna Villani, Gianluigi Vendemiale, Gaetano Serviddio
International Journal of Molecular Sciences (2018) Vol. 20, Iss. 1, pp. 49-49
Open Access | Times Cited: 44
Autoantibodies to apolipoprotein A-I in hepatitis C virus infection: a role in disease progression?
Simon H. Bridge, Sabrina Pagano, John K. Lodge, et al.
Frontiers in Immunology (2025) Vol. 16
Open Access
HCC Immune Surveillance and Antiviral Therapy of Hepatitis C Virus Infection
Solomon Owusu Sekyere, Bernhard Schlevogt, F Mettke, et al.
Liver Cancer (2018) Vol. 8, Iss. 1, pp. 41-65
Open Access | Times Cited: 34
Serum miRNA Are Promising Biomarkers for the Detection of Early Hepatocellular Carcinoma after Treatment with Direct-Acting Antivirals
Devis Pascut, Luisa Cavalletto, Muhammad Yogi Pratama, et al.
Cancers (2019) Vol. 11, Iss. 11, pp. 1773-1773
Open Access | Times Cited: 34
Homeostasis and the functional roles of CD4+ Treg cells in aging
Alexey V. Churov, Кылымбек Ырысбекович Мамашов, Анастасия Васильевна Новицкая
Immunology Letters (2020) Vol. 226, pp. 83-89
Closed Access | Times Cited: 32
Immune system control of hepatitis C virus infection
Johnasha D. Stuart, Eduardo Salinas, Arash Grakoui
Current Opinion in Virology (2020) Vol. 46, pp. 36-44
Open Access | Times Cited: 32
Reversal of Immunity After Clearance of Chronic HCV Infection—All Reset?
Heiner Wedemeyer, Tanvi Khera, Benedikt Strunz, et al.
Frontiers in Immunology (2020) Vol. 11
Open Access | Times Cited: 28
Management of mixed cryoglobulinemia with rituximab: evidence and consensus-based recommendations from the Italian Study Group of Cryoglobulinemia (GISC)
Luca Quartuccio, Alessandra Bortoluzzi, Carlo Alberto Scirè, et al.
Clinical Rheumatology (2022) Vol. 42, Iss. 2, pp. 359-370
Open Access | Times Cited: 16
Pharmacokinetics comparison of two pegylated interferon alfa formulations in healthy volunteers
Marisa Boff Costa, Paulo Dornelles Picon, Guilherme Becker Sander, et al.
BMC Pharmacology and Toxicology (2018) Vol. 19, Iss. 1
Open Access | Times Cited: 28
Adaptive Immune Response against Hepatitis C Virus
Janine Kemming, Robert Thimme, Christoph Neumann‐Haefelin
International Journal of Molecular Sciences (2020) Vol. 21, Iss. 16, pp. 5644-5644
Open Access | Times Cited: 26
Human γδ T Cell Receptor Repertoires in Peripheral Blood Remain Stable Despite Clearance of Persistent Hepatitis C Virus Infection by Direct-Acting Antiviral Drug Therapy
Sarina Ravens, Julia Hengst, Verena Schlapphoff, et al.
Frontiers in Immunology (2018) Vol. 9
Open Access | Times Cited: 27
Treatment for hepatitis C virus-associated mixed cryoglobulinaemia
Núria Montero, Alexandre Favà, Eva Rodríguez, et al.
Cochrane library (2018) Vol. 2018, Iss. 5
Open Access | Times Cited: 26
Page 1 - Next Page

Scroll to top